You are viewing the site in preview mode
Skip to main content
| |
n
|
Median
|
Range (IQR)
|
|---|
|
WBC
|
|
Concentration (× 103/µL)
|
100
|
189
|
102–581 (168–243)
|
|
Total cell number (× 1010)
|
100
|
5.74
|
1.29–16.25 (4.58–7.40)
|
|
Cell dose (× 106/kg body weight)
|
100
|
817.4
|
165.9–5772 (582.3–1091)
|
|
Viability at receipt (%)
|
100
|
99.12
|
95.04–99.78 (98.89–99.39)
|
|
Viability after thaw (%)
|
100
|
63.11
|
41.60–83.66 (56.45–67.97)
|
|
Recovery viable WBC (%)
|
100
|
36
|
21–68 (30–41)
|
|
CD34+
|
|
Concentration (cells/µL)
|
100
|
1649
|
246–10,345 (1200–2450)
|
|
Total cell number (× 106)
|
100
|
484.5
|
39.6–1298 (323.5–675.6)
|
|
Cell dose (× 106/kg body weight)
|
100
|
7.22
|
0.84–68.63 (4.78–9.51)
|
|
Viability at receipt (%)
|
100
|
99.61
|
92.33–100 (99.15–99.85)
|
|
Viability after thaw (%)
|
100
|
94.41
|
69.87–98.43 (90.77–95.94)
|
|
Recovery viable CD34+ (%)
|
100
|
42.20
|
23.20–92.40 (36.33–48.65)
|
|
Cell dose after thaw (× 106/kg body weight)
|
100
|
2.81
|
0.39–29.60 (1.77–3.95)
|
